COLL: Collegium Pharmaceutical Inc. Stocks News on November 17, 2024

COLL

Simply Wall St.

3 days ago

Collegium Pharmaceutical's (NASDAQ:COLL) Performance Is Even Better Than Its Earnings Suggest

COLL

Zacks

4 days ago

Is Collegium Pharmaceutical (COLL) a Great Value Stock Right Now?

COLL

Argus Research

4 days ago

COLL: Lowering target price to $33.00

COLL

GlobeNewswire

5 days ago

Collegium to Participate in Upcoming Investor Conferences

COLL

Simply Wall St.

8 days ago

Collegium Pharmaceutical Third Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags

COLL

GuruFocus.com

9 days ago

Collegium Pharmaceutical Inc (COLL) Q3 2024 Earnings Call Highlights: Record Revenue Growth and ...

COLL

Zacks

9 days ago

Is the Options Market Predicting a Spike in Collegium Pharmaceutical (COLL) Stock?

COLL

Zacks

9 days ago

Here's What Key Metrics Tell Us About Collegium Pharmaceutical (COLL) Q3 Earnings

COLL

Zacks

9 days ago

Collegium Pharmaceutical (COLL) Q3 Earnings and Revenues Lag Estimates

COLL

Associated Press Finance

9 days ago

Collegium Pharmaceutical: Q3 Earnings Snapshot

COLL

GlobeNewswire

9 days ago

Collegium Reports Record Third Quarter 2024 Financial Results

COLL

GlobeNewswire

9 days ago

Collegium Appoints Vikram Karnani as Chief Executive Officer

COLL

GuruFocus.com

11 days ago

What To Expect From Collegium Pharmaceutical Inc (COLL) Q3 2024 Earnings

COLL

Argus Research

11 days ago

COLL: Lowering target price to $35.00

COLL

Zacks

17 days ago

Collegium Pharmaceutical (COLL) Earnings Expected to Grow: What to Know Ahead of Next Week's Release

COLL

Zacks

20 days ago

Collegium Pharmaceutical to Report Q3 Earnings: What's in the Cards?

COLL

Zacks

20 days ago

Should Value Investors Buy Collegium Pharmaceutical (COLL) Stock?

COLL

GlobeNewswire

24 days ago

Collegium to Report Third Quarter 2024 Financial Results on November 7, 2024

COLL

Zacks

a month ago

Are Investors Undervaluing Collegium Pharmaceutical (COLL) Right Now?

COLL

GuruFocus.com

a month ago

Collegium Pharmaceutical Inc (COLL) Q2 2024 Earnings Call Highlights: Strong Revenue Growth and ...

COLL

Argus Research

a month ago

COLL: Lowering target price to $40.00

Breakouts Boost These Three Stocks To All-Time Highs

COLL

Investor's Business Daily

a month ago

Breakouts Boost These Three Stocks To All-Time Highs

COLL

Simply Wall St.

2 months ago

Should We Be Delighted With Collegium Pharmaceutical, Inc.'s (NASDAQ:COLL) ROE Of 46%?

COLL

Zacks

2 months ago

Is Collegium Pharmaceutical (COLL) Stock Undervalued Right Now?

Are Medical Stocks Lagging Context Therapeutics Inc. (CNTX) This Year?

COLL

Zacks

2 months ago

Are Medical Stocks Lagging Context Therapeutics Inc. (CNTX) This Year?

COLL

Zacks

2 months ago

Collegium Pharmaceutical (COLL) Upgraded to Buy: Here's Why

COLL

Zacks

2 months ago

Should Value Investors Buy Collegium Pharmaceutical (COLL) Stock?

COLL

GuruFocus.com

2 months ago

Insider Sale: EVP and General Counsel Shirley Kuhlmann Sells 20,225 Shares of Collegium ...

COLL

MT Newswires

2 months ago

Collegium Pharmaceutical Insider Sold Shares Worth $773,792, According to a Recent SEC Filing

COLL

MT Newswires

2 months ago

Collegium Closes Acquisition of Ironshore Therapeutics; Boosts 2024 Product Revenue

COLL

GlobeNewswire

2 months ago

Collegium Completes Acquisition of Ironshore Therapeutics

COLL

GlobeNewswire

3 months ago

Collegium to Participate in H.C. Wainwright 26th Annual Global Investment Conference

COLL

GlobeNewswire

3 months ago

Collegium Announces Eight Poster Presentations at PAINWeek Conference 2024

COLL

Argus Research

3 months ago

COLL: Raising target price to $40.00

COLL

Argus Research

3 months ago

COLL: Raising target price to $38.00

COLL

Simply Wall St.

3 months ago

Shareholders Will Be Pleased With The Quality of Collegium Pharmaceutical's (NASDAQ:COLL) Earnings

COLL

Zacks

3 months ago

Collegium Pharmaceutical (COLL) Q2 Earnings: How Key Metrics Compare to Wall Street Estimates

COLL

Zacks

3 months ago

Collegium Pharmaceutical (COLL) Beats Q2 Earnings and Revenue Estimates

COLL

Associated Press Finance

3 months ago

Collegium Pharmaceutical: Q2 Earnings Snapshot

COLL

GlobeNewswire

3 months ago

Collegium Reports Second Quarter 2024 Financial Results

COLL

Zacks

3 months ago

Unveiling Collegium Pharmaceutical (COLL) Q2 Outlook: Wall Street Estimates for Key Metrics

Esperion Therapeutics (ESPR) Expected to Beat Earnings Estimates: Can the Stock Move Higher?

COLL

Zacks

3 months ago

Esperion Therapeutics (ESPR) Expected to Beat Earnings Estimates: Can the Stock Move Higher?

COLL

Zacks

4 months ago

Collegium Pharmaceutical (COLL) Earnings Expected to Grow: Should You Buy?

COLL

Zacks

4 months ago

Collegium Pharmaceutical (COLL) Soars 10.6%: Is Further Upside Left in the Stock?

COLL

Pharmaceutical Technology

4 months ago

Collegium buys Ironshore for $525m and enter ADHD market

COLL

MT Newswires

4 months ago

Collegium Pharmaceutical to Acquire Ironshore Therapeutics for $525 Million

COLL

GlobeNewswire

4 months ago

Collegium to Acquire Ironshore Therapeutics, Expanding into Neurology

COLL

GlobeNewswire

4 months ago

Collegium to Report Second Quarter 2024 Financial Results on August 8, 2024

COLL

Argus Research

4 months ago

COLL: Raising target price to $35.00

COLL

Argus Research

4 months ago

COLL: Raising target price to $34.00

COLL

Argus Research

4 months ago

COLL: Lowering target price to $33.00

COLL

Simply Wall St.

5 months ago

Collegium Pharmaceutical (NASDAQ:COLL) shareholders have earned a 19% CAGR over the last five years

COLL

MT Newswires

5 months ago

Collegium Pharmaceutical Says Nucynta Gets FDA Pediatric Exclusivity

COLL

GlobeNewswire

5 months ago

Collegium Obtains Six Month Extension of U.S. Pediatric Exclusivity for Nucynta Franchise

COLL

Insider Monkey

5 months ago

Collegium Pharmaceutical, Inc. (NASDAQ:COLL) Upgraded by Jefferies

COLL

Investing.com

5 months ago

Street calls of the week: Upgrades for Best Buy and Lululemon

COLL

GuruFocus.com

5 months ago

Insider Sale: EVP and General Counsel Shirley Kuhlmann Sells 25,000 Shares of Collegium ...

COLL

MT Newswires

5 months ago

Collegium Pharmaceutical Insider Sold Shares Worth $814,180, According to a Recent SEC Filing

COLL

GuruFocus.com

6 months ago

Insider Sale: EVP & CFO Colleen Tupper Sells Shares of Collegium Pharmaceutical Inc (COLL)

COLL

GlobeNewswire

6 months ago

Collegium to Participate in Jefferies Global Healthcare Conference

COLL

MT Newswires

6 months ago

Collegium Pharmaceutical Launches $35 Million Accelerated Share Repurchase Program

COLL

GlobeNewswire

6 months ago

Collegium Announces $35 Million Accelerated Share Repurchase Program

COLL

GuruFocus.com

6 months ago

Collegium Pharmaceutical Reports First Quarter 2024 Earnings

COLL

Associated Press Finance

6 months ago

Sweetgreen, Natera rise; Collegium Pharmaceutical, Akamai fall, 5/10/2024

COLL

Associated Press

6 months ago

Sweetgreen, Natera rise; Collegium Pharmaceutical, Akamai fall, 5/10/2024

COLL

MT Newswires

6 months ago

--Needham Downgrades Collegium Pharmaceutical to Hold From Buy

COLL

Simply Wall St.

6 months ago

Collegium Pharmaceutical, Inc.'s (NASDAQ:COLL) CEO Looks Like They Deserve Their Pay Packet

COLL

MT Newswires

6 months ago

Collegium Pharmaceutical Q1 Adjusted Net Income, Revenue Rise; 2024 Outlook Reiterated

COLL

Zacks

6 months ago

Collegium Pharmaceutical (COLL) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates

COLL

Zacks

6 months ago

Collegium Pharmaceutical (COLL) Q1 Earnings and Revenues Lag Estimates

COLL

Associated Press Finance

6 months ago

Collegium Pharmaceutical: Q1 Earnings Snapshot

COLL

GlobeNewswire

6 months ago

Collegium Reports First Quarter 2024 Financial Results

COLL

GlobeNewswire

6 months ago

Collegium Announces CEO Transition

COLL

Zacks

6 months ago

Unlocking Q1 Potential of Collegium Pharmaceutical (COLL): Exploring Wall Street Estimates for Key Metrics

COLL

Zacks

6 months ago

Collegium Pharmaceutical (COLL) Earnings Expected to Grow: What to Know Ahead of Next Week's Release

COLL

Zacks

7 months ago

Collegium (COLL) to Report Q1 Earnings: Here's What to Expect

COLL

GlobeNewswire

7 months ago

Collegium Announces Authorized Generic Agreement with Hikma Pharmaceuticals USA Inc. for Nucynta® and Nucynta® ER

COLL

GlobeNewswire

7 months ago

Collegium to Report First Quarter 2024 Financial Results on May 9, 2024

COLL

Argus Research

7 months ago

COLL: Rating increased to a BUY

COLL

Simply Wall St.

7 months ago

Is Collegium Pharmaceutical, Inc.'s (NASDAQ:COLL) ROE Of 25% Impressive?

COLL

GlobeNewswire

7 months ago

Collegium Pharmaceutical, Inc. Announces Redemption of Outstanding 2.625% Convertible Senior Notes Due 2026

COLL

Zacks

7 months ago

Collegium Pharmaceutical (COLL) Stock Sinks As Market Gains: What You Should Know

COLL

GlobeNewswire

7 months ago

Collegium to Participate in 23rd Annual Needham Virtual Healthcare Conference

COLL

Zacks

8 months ago

Are Investors Undervaluing Collegium Pharmaceutical (COLL) Right Now?

COLL

Zacks

8 months ago

Zacks.com featured highlights AppLovin, Kaiser Aluminum, Collegium Pharmaceutical, EMCOR Group and Textron

Strength Seen in Aquestive Therapeutics (AQST): Can Its 16.0% Jump Turn into More Strength?

COLL

Zacks

8 months ago

Strength Seen in Aquestive Therapeutics (AQST): Can Its 16.0% Jump Turn into More Strength?

COLL

Zacks

8 months ago

3 Reasons Why Collegium Pharmaceutical (COLL) Is a Great Growth Stock

COLL

Zacks

9 months ago

Are You Looking for a Top Momentum Pick? Why Collegium Pharmaceutical (COLL) is a Great Choice

COLL

Zacks

9 months ago

Is Collegium Pharmaceutical (COLL) Stock Undervalued Right Now?

Best Value Stocks to Buy for February 29th

COLL

Zacks

9 months ago

Best Value Stocks to Buy for February 29th

COLL

GuruFocus.com

9 months ago

Insider Sell: EVP & Chief Commercial Officer Scott Dreyer Sells 10,000 Shares of Collegium ...

This Unsung Pharmaceutical Stock In The IBD 50 Hit A Buy Zone. Here's Why.

COLL

Investor's Business Daily

9 months ago

This Unsung Pharmaceutical Stock In The IBD 50 Hit A Buy Zone. Here's Why.

COLL

Simply Wall St.

9 months ago

Collegium Pharmaceutical Full Year 2023 Earnings: EPS Beats Expectations

COLL

Insider Monkey

9 months ago

Collegium Pharmaceutical, Inc. (NASDAQ:COLL) Q4 2023 Earnings Call Transcript

COLL

Thomson Reuters StreetEvents

9 months ago

Q4 2023 Collegium Pharmaceutical Inc Earnings Call

COLL

Zacks

9 months ago

Here's What Key Metrics Tell Us About Collegium Pharmaceutical (COLL) Q4 Earnings

COLL

Associated Press Finance

9 months ago

Collegium Pharmaceutical: Q4 Earnings Snapshot

COLL

GuruFocus.com

9 months ago

Collegium Pharmaceutical Inc Reports Record Earnings for Q4 and Full-Year 2023

COLL

GlobeNewswire

9 months ago

Collegium Reports Record Fourth Quarter and Full-Year 2023 Financial Results

COLL

Insider Monkey

9 months ago

Latest Collegium Pharmaceutical Inc. (COLL) News on November 17, 2024

Share on Social Networks: